Is diabetes mellitus worth treating?;Czy warto leczyć cukrzyce ciazowa?

Ginekologia Polska

Volumn 85, Issue 3, 2014, Pages 220-225

  Towpik, Iwona ^a   Wender Ozegowska, Ewa ^b  

^a Przyszpitalna Poradnia Diabetologiczna   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Gestational diabetes; Long term complications; Pregnancy complications; Treatment effects

Indexed keywords

ANTIDIABETIC AGENT;

ADULT; ARTICLE; CHILD; FEMALE; HUMAN; NEWBORN; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; RISK FACTOR; TREATMENT OUTCOME;

ADULT; CHILD; DIABETES, GESTATIONAL; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INFANT, NEWBORN; PREGNANCY; PREGNANCY OUTCOME; RISK FACTORS; TREATMENT OUTCOME;

EID: 84900447007     PISSN: 00170011     EISSN: None     Source Type: Journal    
DOI: 10.17772/gp/1717     Document Type: Article

References (51)

1. Bucley B, Harreiter J, Damm P, [et al.]. Gestational diabetes mellitus in Europe: prevalence, current screening practice and barriers to screening. Diabet Med. 2012, 29 (2), 844-854.
2. Sacks DA, Hadden DR, Maresh M, [et al.]. Frequency of gestational diabetes mellitus at collaborating centrs based on IADPSG consensus panel-recommended criteria: the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Diabetes Care 2012, 35 (3), 526-528.
3. Freinkel N. Banting Lecture 1980: Of pregnency and progeny'. Diabetes. 1980, 29:1023-1035.
4. Malinowska-Polubiec A, Czajkowski K, Sotowska A, v Zgony okoloporodowe i wady wrodzone w ciazy powikłanej cukrzyca ciazowa. Perinatologia, Neonatologia i Ginekologia. 2008, 1, 169-174.
5. Kerenyi Z, Tomas G, Kivimaki M, [et al.]. Maternal glycaemia and risk of large-for-gestational-age babies in a population-based screening. Diabetes Care. 2009, 32, 2200-2205.
6. The HAPO Study Cooperative Resarch Group. Hyperglycemia and Adverse Pregnancy Outcomes. N Engl J Med. 2008, 358, 1991-2002.
7. Kaim I, Cyganek K,Wójtowicz A, [et al.]. Przebieg ciazy powiklanej cukrzyca przedciazowa typu 1 i 2 i cukrzyca ciazowa. Przeglad Ginekologiczno-Połozniczy. 2009, 9, 121-125.
8. Schaefer-Graf U, Graf K, Kulbacka I, [et al.]. Maternal lipids as strong determinants of fetal environment and growth in pregnancies with gestational diabetes mellitus. Diabetes Care. 2008, 31, 1858-1863.
9. Herrera E, Ortega-Senovilla H. Disturbances in lipid metabolism in diabetic pregnancy-are these the cause of the problem? Best Pract Res Clin Endocrinol Metab. 2010, 4, 515-525.
10. Ate'gbo J, Grissa O, Yessoufou A, [et al.]. Modulation of adipokines and cytokines in gestational diabetes and macrosomia. J Clin Endocrinol Metab. 2006, 10, 4137-4143.
11. Wang J,Wang S, Shang L, [et al.]. Relationship of adiponectin and resistin levels in umbilical and maternal serum with fetal macrosomia. J Obstet Gynecol Res. 2010, 3, 533-537.
12. Velliga A, Zawiejska A, Harreiter J, [et al.]. Associations of Body Mass Index (maternal BMI) and gestational diabetes mellitus with neonatal and maternal pregnancy outcomes in a Multicentre European Database.Diabetes and Pregnancy Vitamin D and Lifestyle Intervention for Gestational Diabetes Mellitus Prevention. ISRN Obesity. 2012, ID: 424010.
13. Hillier T, Pedula K, Vesco K, [et al.]. Excess gestational weight gain: modifying fetal macrosomia risk associated with maternal glucose. Obstet Gynecol. 2008, 5, 1007-1014.
14. Gutaj P, Wender-Ozegowska E, Mantaj U, [et al.]. Matczyny BMI oraz przyrost masy ciała w cia{ognek}zy i ich wplyw na wyniki połoznicze u kobiet z cukrzyca{ognek} cia{ognek}zowa{ognek}. Ginekol Pol. 2011, 82, 827-833.
15. The HAPO Study Cooperative Resarch Group. The Hyperglycemia and Adverse Pregnancy Outcome Study. Associatons of GDM and obesity with pregnancy outcomes. Diabetes Care. 2012, 35, 780-786.
16. Carpenter M. Gestational diabetes, pregnancy hypertension and late vascular disease. Diabetes Care. 2007, 30 (Suppl 7), 246-250.
17. Kim C. Gestational diabetes:risk, management, and treatment options. Int J Womens Health. 2010, 2, 339-351.
18. Pettitt D, Baird H, Aleck K, [et al.]. Excessive obesity in offspring of Pima Indian women with diabetes during pregnancy. N Engl J Med. 1983, 5, 242-245.
19. Dabelea D. The predisposition to obesity and diabetes in offspring of diabetic mothers. Diabetes Care. 2007, 30 (Suppl 2), 169-174.
20. Silverman B, Rizzo T, Cho N, Metzger B. Long-term effects of the intrauterine environment. The Norwestern University Diabetes in Pregnancy Center. Diabetes Care. 1998, 21 (Suppl 2), 142-149.
21. Boerschmann H, Oflüger M, Henneberger L, [et al.]. Prevalence and predictors of overweight and insulin resistance in offspring of mothers with gestational diabetes mellitus. Diabetes Care. 2010, 8, 1845-1849.
22. Wróblewska-Seniuk K, Wender-Ozegowska E, Szczapa J. Long-term effects of diabetes during pregnancy on the offspring. Pediatr Diabetes. 2009, 7, 432-440.
23. Kim S, England L, Sharma J, Njoroge T. Gestational diabetes mellitus and risk of childhood overweight and obesity in offspring: a systematic review. Exp Diabetes Res. 2011, ID:541308, 9.
24. Fernandez-Morera J, Rodriguez-Rodero S, Menendez-Torre E, Fraga F. The possible role of epigenetics in gestational diabetes: cause, consequence, or both. Obst Gynecol Int. 2010, ID: 605163, 7.
25. Yessoufou A, Moutairou K. Maternal diabetes in pregnancy:early and long-term outcomes on the offspring and concept of ,,metabolic memory". Exp Diabetes Res. 2011, ID:218598, 12.
26. Park J, Stoffers D, Nicholls R, Simmons R. Development of type 2 diabetes following intrauterine growth retardation in rats is associated with progressive epigenetic silencing of Pdx1. J Clin Invest. 2008, 6, 2316-2324.
27. Bouchard L, Thibault S, Guay S-P, [et al.]. Leptin gene epigenetic adaptation to impaired glucose metabolism during pregnancy. Diabetes Care. 2010, 33, 2436-2441.
28. Tam W, Wan Ma R, Yang X, [et al.]. Glucose intolerance and cardiometabolic risk in adolescents exposed to maternal gestational diabetes. A 15-year follow-up study. Diabetes Care. 2010, 6, 1382-1384.
29. Manderson J, Mullan B, Patterson C, [et al.]. Cardiovascular and metabolic abnormalities in the offspring of diabetic pregnancy. Diabetologia. 2002, 45, 991-996.
30. Marco L, McCloskey K, Vuillermin P, [et al.]. Cardiovascular disease risk in the offspring of diabetic women:the impact of the intrauterine environment. Exp Diabetes Res. 2012, ID:565160, 10.
31. Ornoy A. Growth and neurodevelopment outcome of children born to mothers with pregestational and gestational diabetes. Pediatr Endocrinol Rev. 2005, 2, 104-113.
32. Van Lieshout R, Voruganti L. Diabetes mellitus during pregnancy and increased risk of schizophrenia in offspring:a reviev of evidence and putative mechanisms. J Psychiatry Neurosci. 2008, 5, 395-404.
33. Bellamy L, Casas J-P, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 2009; 373:1773-1779.
34. Kim K, Newton K, Knopp R. Gestational Diabetes and incidence of Type 2 Diabetes. Diabetes Care. 2002, 10, 1862-1868.
35. Buraczyk M, Kinalski M, Kinalska I. Wystepowanie zaburzen tolerancji glukozy u kobiet po przebyciu cukrzycy ciazowej. Przeglad Kardiodiabetologiczny. 2007, 3, 163-167.
36. Ogonowski J, Miazgowski T. The prevalence of 6 weeks postpartum abnormal glucose tolerance in Caucasian women with gestational diabetes. Diabetes Res Clin Pract. 2009, 3, 239-244.
37. Füchtenbusch M, Ferber K, Standl E, Ziegler A. Prediction of type 1 diabetes postpartum in patients with gestational diabetes mellitus by combined islet cell autoantibody screening: a prospective multicenter study. Diabetes. 1997, 9, 1459-1467.
38. Okruszko A, Kinalski M, Kuźmicki M, [et al.]. Mutacje genu glukokinazy w cukrzycy ciezarnych w populacji polskiej. Prognozowanie ryzyka rozwoju cukrzycy po ciazy. Przeg Lek. 2007, 64, 401-405.
39. Tovar A, Chasan-Taber L, Eggleston E, Oken E. Postpartum screening for diabetes among women with history of gestational diabetes mellitus. Prev Chronic Dis. 2011, 6, A124(1-11).
40. O'Sullivan JB. Subsequent morbidity among gestational diabetic women. In: Carbohydrate Metabolism in Pregnancy and Newborn. Ed. Sutherland HW, Stowers JM. Edinburg: Churchil Livingstone. 1984:174-180.
41. Lauenborg J, Mathiesen E, Hansen T, [et al.]. The prevalence of the metabolic syndrome in a Danish population of women with previous gestational diabetes mellitus is three-fold higer than in the generaln population. J Clin Endocrinol Metab. 2005, 7, 4004-4010.
42. Wender-Ozegowska E, Sporna M, Zawiejska A, [et al.]. Wykladniki zespolu metabolicznego u kobiet po przebytej cukrzycy ciazowej. Pol Arch Med Wewn. 2007, 10, 457-461.
43. Shah B, Retnakaran R, Booth G. Increased risk of cardiovascular disease in young women following gestational diabetes. Diabetes . 2008, 8, 1668-1669.
44. Vrachnis N, Augoulea A, Iliodromiti Z, [et al.]. Previous gestational diabetes mellitus and markers of cardiovascular risk. Int J Endocrinol. 2012, ID:458610, 6.
45. Crowther C. and the ACHOIS Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005, 24, 2477-2486.
46. Landon M, Spong C, Thom E, [ et al.]. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J of Med. 2009, 14, 1339-1348.
47. Alwan N, Tuffnell D, West J. Treatment for gestational diabetes. Cochrane Database of Systematic Reviews 2009, 3, CD003395 (online).4
48. Langer O, Yogev Y, Most O, Xenakis E. Gestational diabetes:the consequences of non treating. Am J Obstet Gynecol. 2005, 4, 989-997.
49. Horvarth K, Koch K, Jeitler K, [et al.].Effects of teratment in women with geststional diabetes mellitus:systematic reviev and meta-analysis. BMJ. 2010, 1, 340:C1395.
50. Falavigna M, Schmidt MI, Trujillo J, [et al.].Effectiveness of geststional diabetes treatment:A systematic review with guality of evidence assessment. Diabetes Res Clin Pract. 2012, 98, 396-405.
51. Hartling L, Dryden DM,Guthrie A, [et al.].Benefits and harms of treating gestational diabetes mellitus: a systematic reviev and meta-analysis for the U.S.Preventive Service Task Force and the National Institutes of Health Office of Medical Applications of Research. Ann Intern Med. 2013, 159,123-129.